Search results for:
enzalutamide
enzalutamide
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Xtandi |
CAPSULE, ORAL |
40 mg |
|
|
|
|
Last updated: Apr. 11, 2024
- HAZ-MED: Group 1
- Hormonal Therapy: This drug is a hormonal therapy in used in oncologic conditions. This drug may be resumed by a hospitalist or non-oncology healthcare provider without contacting an oncology pharmacy specialist or consulting an oncologist.
XTANDI is classified as non-formulary, not stocked. Inpatients may use their own supply. Initiation should be deferred to after discharge.
Reviewed: January 22, 2013 (Xtandi)